Cargando…
Assessment of Clinical Validity of a Breast Cancer Risk Model Combining Genetic and Clinical Information
BACKGROUND: The Gail model is widely used for the assessment of risk of invasive breast cancer based on recognized clinical risk factors. In recent years, a substantial number of single-nucleotide polymorphisms (SNPs) associated with breast cancer risk have been identified. However, it remains uncle...
Autores principales: | Mealiffe, Matthew E., Stokowski, Renee P., Rhees, Brian K., Prentice, Ross L., Pettinger, Mary, Hinds, David A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970578/ https://www.ncbi.nlm.nih.gov/pubmed/20956782 http://dx.doi.org/10.1093/jnci/djq388 |
Ejemplares similares
-
Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer
por: Lønning, Per E., et al.
Publicado: (2022) -
Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/CAP ISH group 4 breast cancer
por: Gupta, Swati, et al.
Publicado: (2019) -
Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk
por: Huang, Ying, et al.
Publicado: (2012) -
Genetic variants in the MRPS30 region and postmenopausal breast cancer risk
por: Huang, Ying, et al.
Publicado: (2011) -
Genetic variants in the MRPS30 region and postmenopausal breast cancer risk
por: Huang, Ying, et al.
Publicado: (2012)